DIVIS LABORATORIES
|
DIVIS LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
| Equity - Authorised | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr | ₹60 Cr |
| Equity - Issued | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
| Equity Paid Up | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹53 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 | ₹2.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹16,708 Cr | ₹14,916 Cr | ₹13,518 Cr | ₹12,714 Cr | ₹11,675 Cr |
| Securities Premium | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr | ₹80 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹15,370 Cr | ₹13,400 Cr | ₹11,786 Cr | ₹10,959 Cr | ₹9,989 Cr |
| General Reserves | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr | ₹1,000 Cr |
| Other Reserves | ₹258 Cr | ₹436 Cr | ₹652 Cr | ₹675 Cr | ₹606 Cr |
| Reserve excluding Revaluation Reserve | ₹16,708 Cr | ₹14,916 Cr | ₹13,518 Cr | ₹12,714 Cr | ₹11,675 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹16,761 Cr | ₹14,969 Cr | ₹13,571 Cr | ₹12,767 Cr | ₹11,728 Cr |
| Minority Interest | - | - | - | - | - |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | - | - | - | - | - |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | - | - | - | - | - |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | - | - | - | - | - |
| Unsecured Loans | - | - | - | - | - |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | - | - |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹455 Cr | ₹498 Cr | ₹572 Cr | ₹523 Cr | ₹407 Cr |
| Deferred Tax Assets | ₹52 Cr | ₹26 Cr | ₹30 Cr | ₹31 Cr | ₹36 Cr |
| Deferred Tax Liability | ₹507 Cr | ₹524 Cr | ₹602 Cr | ₹554 Cr | ₹443 Cr |
| Other Long Term Liabilities | ₹679 Cr | ₹2.00 Cr | ₹2.00 Cr | ₹3.00 Cr | ₹2.87 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹81 Cr | - | ₹37 Cr | ₹31 Cr | ₹27 Cr |
| Total Non-Current Liabilities | ₹1,215 Cr | ₹500 Cr | ₹611 Cr | ₹557 Cr | ₹437 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹1,211 Cr | ₹910 Cr | ₹824 Cr | ₹762 Cr | ₹796 Cr |
| Sundry Creditors | ₹1,211 Cr | ₹910 Cr | ₹824 Cr | ₹762 Cr | ₹796 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹760 Cr | ₹486 Cr | ₹404 Cr | ₹332 Cr | ₹394 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹83 Cr | ₹40 Cr | ₹34 Cr | ₹33 Cr | ₹17 Cr |
| Interest Accrued But Not Due | - | - | - | - | - |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹677 Cr | ₹446 Cr | ₹370 Cr | ₹299 Cr | ₹377 Cr |
| Short Term Borrowings | - | ₹2.00 Cr | - | - | - |
| Secured ST Loans repayable on Demands | - | ₹2.00 Cr | - | - | - |
| Working Capital Loans- Sec | - | ₹2.00 Cr | - | - | - |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | - | ₹-2.00 Cr | - | - | - |
| Short Term Provisions | ₹931 Cr | ₹850 Cr | ₹527 Cr | ₹445 Cr | ₹1,265 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹871 Cr | ₹796 Cr | ₹520 Cr | ₹440 Cr | ₹1,261 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹60 Cr | ₹54 Cr | ₹7.00 Cr | ₹5.00 Cr | ₹4.15 Cr |
| Total Current Liabilities | ₹2,902 Cr | ₹2,248 Cr | ₹1,755 Cr | ₹1,539 Cr | ₹2,454 Cr |
| Total Liabilities | ₹20,878 Cr | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr |
| ASSETS | |||||
| Gross Block | ₹9,413 Cr | ₹7,868 Cr | ₹6,760 Cr | ₹6,365 Cr | ₹5,624 Cr |
| Less: Accumulated Depreciation | ₹2,885 Cr | ₹2,426 Cr | ₹2,021 Cr | ₹1,643 Cr | ₹1,299 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹6,528 Cr | ₹5,442 Cr | ₹4,739 Cr | ₹4,722 Cr | ₹4,325 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹2,113 Cr | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr |
| Non Current Investments | ₹69 Cr | ₹65 Cr | ₹82 Cr | ₹77 Cr | ₹72 Cr |
| Long Term Investment | ₹69 Cr | ₹65 Cr | ₹82 Cr | ₹77 Cr | ₹72 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹69 Cr | ₹65 Cr | ₹82 Cr | ₹77 Cr | ₹72 Cr |
| Long Term Loans & Advances | ₹204 Cr | ₹301 Cr | ₹176 Cr | ₹97 Cr | ₹134 Cr |
| Other Non Current Assets | ₹9.00 Cr | ₹10.00 Cr | ₹10.00 Cr | ₹5.00 Cr | ₹8.05 Cr |
| Total Non-Current Assets | ₹8,923 Cr | ₹6,840 Cr | ₹5,785 Cr | ₹5,113 Cr | ₹5,009 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹3,954 Cr | ₹3,236 Cr | ₹3,184 Cr | ₹3,000 Cr | ₹2,829 Cr |
| Raw Materials | ₹1,436 Cr | ₹1,037 Cr | ₹1,091 Cr | ₹972 Cr | ₹773 Cr |
| Work-in Progress | ₹1,969 Cr | ₹1,698 Cr | ₹1,620 Cr | ₹1,526 Cr | ₹1,532 Cr |
| Finished Goods | ₹172 Cr | ₹129 Cr | ₹150 Cr | ₹175 Cr | ₹154 Cr |
| Packing Materials | ₹15 Cr | ₹9.00 Cr | ₹8.00 Cr | ₹9.00 Cr | ₹9.16 Cr |
| Stores  and Spare | ₹185 Cr | ₹157 Cr | ₹148 Cr | ₹191 Cr | ₹196 Cr |
| Other Inventory | ₹177 Cr | ₹206 Cr | ₹167 Cr | ₹127 Cr | ₹165 Cr |
| Sundry Debtors | ₹2,984 Cr | ₹2,731 Cr | ₹2,156 Cr | ₹1,793 Cr | ₹2,424 Cr |
| Debtors more than Six months | ₹110 Cr | ₹17 Cr | ₹18 Cr | ₹11 Cr | ₹10 Cr |
| Debtors Others | ₹2,883 Cr | ₹2,721 Cr | ₹2,148 Cr | ₹1,788 Cr | ₹2,419 Cr |
| Cash and Bank | ₹3,414 Cr | ₹3,715 Cr | ₹3,980 Cr | ₹4,214 Cr | ₹2,819 Cr |
| Cash in hand | ₹1.00 Cr | ₹1.00 Cr | ₹1.00 Cr | ₹1.00 Cr | ₹0.71 Cr |
| Balances at Bank | ₹3,413 Cr | ₹3,714 Cr | ₹3,979 Cr | ₹4,213 Cr | ₹2,818 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹142 Cr | ₹39 Cr | ₹38 Cr | ₹28 Cr | ₹30 Cr |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹26 Cr | ₹37 Cr | ₹36 Cr | ₹26 Cr | ₹27 Cr |
| Other current_assets | ₹116 Cr | ₹2.00 Cr | ₹2.00 Cr | ₹2.00 Cr | ₹2.60 Cr |
| Short Term Loans and Advances | ₹1,461 Cr | ₹1,156 Cr | ₹794 Cr | ₹715 Cr | ₹1,509 Cr |
| Advances recoverable in cash or in kind | ₹240 Cr | ₹87 Cr | ₹80 Cr | ₹34 Cr | ₹87 Cr |
| Advance income tax and TDS | ₹874 Cr | ₹809 Cr | ₹505 Cr | ₹536 Cr | ₹1,317 Cr |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹347 Cr | ₹260 Cr | ₹209 Cr | ₹145 Cr | ₹105 Cr |
| Total Current Assets | ₹11,955 Cr | ₹10,877 Cr | ₹10,152 Cr | ₹9,750 Cr | ₹9,610 Cr |
| Net Current Assets (Including Current Investments) | ₹9,053 Cr | ₹8,629 Cr | ₹8,397 Cr | ₹8,211 Cr | ₹7,156 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹20,878 Cr | ₹17,717 Cr | ₹15,937 Cr | ₹14,863 Cr | ₹14,619 Cr |
| Contingent Liabilities | ₹8.00 Cr | ₹8.00 Cr | ₹257 Cr | ₹89 Cr | ₹89 Cr |
| Total Debt | - | ₹2.00 Cr | - | - | - |
| Book Value | - | 564.87 | 512.11 | 481.77 | 441.82 |
| Adjusted Book Value | 632.49 | 564.87 | 512.11 | 481.77 | 441.82 |
Compare Balance Sheet of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹192,398.6 Cr | -1% | 7.3% | 7.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | -0.8% | 3.5% | 14.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | -0.9% | 10.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -2.1% | -1.8% | -6% | Stock Analytics | |
| MANKIND PHARMA | ₹103,472.0 Cr | -2.4% | 1.2% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -5.8% | -13.2% | -7.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1% |
7.3% |
7.6% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses